GSK's melanoma drugs may steal market from Roche

>>> now to the news a lot of people woke up to this morning about a so-called smart bomb new breast cancer drug, a first of its kind medication approved today by the fda. it is getting a lot of attention tonight. but this new drug isn't an answer for eve

* Drug is first of its kind for solid tumors * To carry warnings on liver, heart damage WASHINGTON, Feb 22 (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast

Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today. It's been a long time coming but Roche (NASDAQOTH: RHHBY ) and ImmunoGen's (NASDAQ: IMGN ) breast cancer drug T-DM1 is finally approved

WASHINGTON (AP) — SMART BOMB DRUG: Federal health regulators approved an innovative breast cancer drug on Friday that targets tumor cells while sparing healthy ones. PHARMA COCKTAIL: The drug Kadcyla from Roche combines the older drug Herceptin with a po

(AP) — The Food and Drug Administration has approved a first-of-a-kind breast cancer medication that targets tumor cells while sparing healthy ones, relying on research conducted by Rush University Medical Center. The drug Kadcyla from Roche combines the

The Food and Drug Administration (FDA) has approved a new drug for treating breast cancer that effectively targets tumors, thus minimizing damage to other cells in the body. The drug Kadcyla (kad-SY’-luh) from Roche combines the established drug Hercepti